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Abstract

Background The acute response to genotoxic carcinogens in rats is an important model for researching cancer
initiation events. In this report we define the normal rat colonic epithelium by describing transcriptional
events along the anterior-posterior axis and then investigate the acute effects of azoxymethane (AOM) on
gene expression, with a particular emphasis on pathways associated with the maintenance of genomic integrity
in the proximal and distal compartments using whole genome expression microarrays. Results There are large
transcriptional changes that occur in epithelial gene expression along the anterior-posterior axis of the normal
healthy rat colon. AOM administration superimposes substantial changes on these basal gene expression
patterns in both the distal and proximal rat colonic epithelium. In particular, the pathways associated with cell
cycle and DNA damage and repair processes appear to be disrupted in favour of apoptosis. Conclusions The
healthy rats' colon exhibits extensive gene expression changes between its proximal and distal ends. The most
common changes are associated with metabolism, but more subtle expression changes in genes involved in
genomic homeostasis are also evident. These latter changes presumably protect and maintain a healthy colonic
epithelium against incidental dietary and environmental insults. AOM induces substantial changes in gene
expression, resulting in an early switch in the cell cycle process, involving p53 signalling, towards cell cycle
arrest leading to the more effective process of apoptosis to counteract this genotoxic insult.
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Abstract
Background: The acute response to genotoxic carcinogens in rats is an important model for researching cancer
initiation events. In this report we define the normal rat colonic epithelium by describing transcriptional events
along the anterior-posterior axis and then investigate the acute effects of azoxymethane (AOM) on gene expression,
with a particular emphasis on pathways associated with the maintenance of genomic integrity in the proximal and
distal compartments using whole genome expression microarrays.
Results: There are large transcriptional changes that occur in epithelial gene expression along the anterior-posterior
axis of the normal healthy rat colon. AOM administration superimposes substantial changes on these basal gene
expression patterns in both the distal and proximal rat colonic epithelium. In particular, the pathways associated
with cell cycle and DNA damage and repair processes appear to be disrupted in favour of apoptosis.
Conclusions: The healthy rats’ colon exhibits extensive gene expression changes between its proximal and distal
ends. The most common changes are associated with metabolism, but more subtle expression changes in genes
involved in genomic homeostasis are also evident. These latter changes presumably protect and maintain a healthy
colonic epithelium against incidental dietary and environmental insults. AOM induces substantial changes in gene
expression, resulting in an early switch in the cell cycle process, involving p53 signalling, towards cell cycle arrest
leading to the more effective process of apoptosis to counteract this genotoxic insult.
Keywords: Colorectal cancer, Azoxymethane, Rats, Gene expression

Background
Colorectal cancer (CRC) is the third most common
cancer in males and second most common in females
world-wide [1]. The majority of these cancers are considered preventable by appropriate diet and associated
lifestyle factors [2]. Dietary patterns consisting of micronutrient dense, low-fat, high-fibre food patterns protect
against colorectal cancer [3,4]. Conversely, specific
sources of dietary protein have been linked to increased
CRC risk [5] and animal studies have indicated that
different dietary proteins can induce DNA damage in
the rats’ colon [6]. Consequently, the challenge is to
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translate this information into strategies that prevent CRC.
One of the first steps to doing this is to understand the
early molecular events involved in oncogenesis and develop
hypotheses on the role played by environmental factors
such as diet in this process.
The azoxymethane (AOM)-treated rodent provides an
important tool in the study of sporadic CRC development
and progression [7]. It has been used extensively to study
colon carcinogenesis and its prevention, in at least two
formats that model different aspects of CRC [8,9]. One
version of this model studies tumour development
(at least 14 weeks post-treatment) to find the underlying
signalling pathways of colon carcinogenesis. For instance,
it has been used to investigate mouse models of colorectal
carcinogenesis using gene expression profiling and has
provided significant insights into the role of reactivated
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Figure 1 Global gene expression depicted as a principal component analyses (PCA, covariate) showing the A) PC1 and PC2 and B) PC1
and PC3, illustrating the effect of six hours post-AOM on proximal and distal sections of the rat colon (AOM distal▲, AOM proximal ■,
saline distal “light gray triangle symbol” and saline proximal “light gray square symbol”).
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embryonic signatures in colon tumours [10]. The other
main version of the AOM model is the ‘cancer initiation’
model, which is used to study the early response to the
carcinogen, where tissues are harvested shortly after
treatment (around 0–48 hours) [11]. Using this latter
acute AOM model, we report here some of the early
transcriptional events induced by this carcinogen in
mucosal tissue along the length of the colon in rats.

Results and discussion
The colonic epithelium is one of the largest epithelial
barriers in the body and is in a constant state of selfrenewal. In order to understand the effects of a carcinogenic insult to this tissue, it is important to develop an
understanding of the natural morphologic and molecular
features of the normal rat colon. It has been demonstrated
that rat colonic stem cells are located in different positions
and behave differently in crypts sampled from different
points along the anterior-posterior length of the colon [12].
In distal sections, stem cells are located in the crypt base
from whence progeny differentiating cells then migrate up
towards the lumen, ultimately undergoing anoikis and
sloughing off into the digesta [12]. In proximal sections,
stem cells are located in the middle one-third of the crypt.
Differentiating cells migrate bi-directionally from this
source with some differentiating colonocytes migrating
towards the lumen, while others migrate into the crypt
base [12]. Our own data confirm the observations of
others that the crypt height in the normal rat distal colon
is greater than that for the proximal colon (34.4 ± 0.26 and
27.4 ± 0.27 cells respectively, P<0.0001, n=10). Despite
these morphological differences, no significant differences
in rates of baseline apoptosis between the proximal and
distal normal (saline treated) colon (0.018 ± 0.012 and
0.057 ± 0.028 cells per crypt, respectively) were observed.
It has been shown in mice that significant numbers of
genes are differentially expressed along functionally
distinct regions of the gastrointestinal tract [13,14] and
this is also true for the normal human colon [15,16].
When gene expression in the normal colon of the rat
was examined at the level of individual genes, the proximal
expression profile differed markedly from that of the distal
colonic epithelium with 4527 genes differentially expressed
(False Discovery Rate (FDR) 0.05) (Figure 1). These genes
are listed in Additional file 1: Table S1. This microarray
dataset was also validated by demonstrating that the top 8
genes most differentially expressed between the proximal
and distal colon were also 100% consistently differentially
expressed using real time RTPCR (as shown in Additional
file 1: Table S3).
When the functional groupings of these genes were
considered through pathway analysis, most of the top 20
pathways identified were broadly associated with intestinal
metabolism functions (see Figure 2 for the top 20
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pathways). The magnitude of these changes in expression
can be very large (changes up to 104 fold). We consider
this association with metabolism most likely reflects the
changing profile of digestive functions naturally occurring
along the length of the colon. Consequently, these positionassociated profiles provide the background against which
changes in gene expression induced by colonic carcinogens
need to be assessed.
The carcinogens AOM and 1,2-Dimethylhydrazine are
metabolised by cytochrome P450 (CYP2E1) into methylazoxymethanol. In turn this breaks down to form highly
reactive alkylating species which can lead to the addition
of methyl adducts at the O6 position of Guanine residues
in the DNA to form the promutagenic modified base O6
methyl guanine (O6-mdGua). If this modified base is not
repaired, it can lead to G:C to A:T transition mutations
during replication Tan [17,18]. These DNA adduct-induced
mutations are found commonly in colorectal cancers [18].
So not surprisingly, AOM induces substantial transcriptional changes in the mucosa of the rat colon six hours
after subcutaneous administration (Figure 1). The genes
differentially expressed in response to AOM are listed in
Additional file 1: Table S1. There were 1960 and 9441
genes differently expressed (FDR 0.05) in the proximal and
distal colons respectively of AOM-treated rats when compared with the same tissues from normal (saline treated)
animals. The fold changes were up to 6.6 in the proximal
and 10.7 in the distal colon.
At a whole genome level, principal component analysis
(PCA) revealed that the magnitude of the site effect on
gene expression (proximal versus distal colon) was equal to
or greater than that of AOM for the two highest principal
components (PCs) (Figure 1A). Further examination of the
PCA revealed that PC1 and PC3 best explained the effect
of AOM (Figure 1B), and PC1 and PC4 best explained the
effect of ‘site’ (not shown). As it has been previously shown
that the greatest effects of AOM in the rat, in terms of
tumours numbers are exhibited in the distal colon [10] and
human tumours predominately occur in the most distal
colonic region, i.e. sigmoid colon and the rectum [16], it is
not surprising that there almost 10-fold more genes
expressed in the distal rat colon at 6 hours post treatment.
As a consequence, this report will concentrate predominantly on the effects this carcinogen in this colonic region
with a particular focus on DNA damage and repair.
In a previous study using the “cancer initiation” AOM
model in Sprague Dawley rats, Tan et al. measured levels of
O6-mdGua accumulating in the DNA from a number of
tissues harvested 6 hours and 48 hours after subcutaneous
injection of this carcinogen. They observed that 6 hours
after AOM exposure, the highest levels O6-mdGua
occurred in the following tissues (in order of highest to
lowest): liver, distal colon, proximal colon, proximal small
intestine (SI), and kidney. The stomach, distal SI, bladder,
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Figure 2 The top 20 pathways differentially expressed along the length of the normal healthy rat colon (proximal compared to distal)
depicted as up (□), down (■) or no overlap with the dataset (i.e. genes in the canonical pathway but not differentially expressed)
(gray square symbol).

spleen, blood and lung had relatively low levels O6mdGua. While levels of this highly mutagenic alkylation
product had dropped in most tissues tested by 48 h post
AOM administration, O6-mdGua levels remained high at
this time point in the proximal and distal colon, kidney
and bladder. This is a significant finding as the distal colon
is more prone to AOM induced tumours than any other
tissue [17] and tumours in the bladder and kidney have
been observed in animals treated with high levels of
dimethyl hydrazine, a precursor of AOM [19].
A key enzyme involved in the repair of O6-mdGua is
O-6-methylguanine DNA methyltransferase (MGMT). In a
‘suicide’ reaction the methyl adduct from one modified
guanine base is transferred to a cysteine residue in the
active site of one molecule of enzyme resulting in the
inactivation of that molecule of enzyme and earmarking it
for ubiquitination and degradation [20]. Interestingly, in the
current study, in the normal colon, the level of expression
of MGMT was greater in the distal section compared to
the proximal section (Figure 3). This would be consistent
with an adaptation to a higher basal metabolic demand for
DNA adduct repair in the distal colonic mucosa relative to
the proximal. This could arise in response to dietary
mutagens in the colonic digesta becoming more concentrated as more and more water is removed during its transit
from proximal to distal colon. Whatever the drivers may
be, however, this change in MGMT levels from proximal to
distal colon is likely to form a part of an innate homeostatic

process to maintain genomic integrity in a healthy colonic
mucosa.
Six hours after the administration of AOM, MGMT
expression was down-regulated in both the proximal and
distal colonic epithelium (fold changes −1.39 and −1.79
respectively). As there are high levels of O6-mdGua
present in the DNA of the distal colon at this time [17]
and with MGMT being the primary enzyme for repair of
DNA methyl adducts, it appears that MGMT is rapidly
depleted instead of being up-regulated in response to
AOM. As the animals survive AOM challenge well
with no apparent significant loss of colonic function,
this observation suggests that other repair mechanisms
are brought into play to ensure the rapid return to normal
colonic function.
Further analysis revealed that the expression of a
number of other DNA repair and damage genes was also
altered in response to AOM, particularly in the distal colon
(see Figure 3 and Additional file 1: Table S2). Expression of
the damaged DNA binding and sensing H2A histone family
member X (H2AFX) gene was significantly up-regulated
in response to AOM (p=3.08E-08, fold change 1.5)
(Figure 3), confirming that repair mechanisms other than
MGMT are deployed in response to the AOM perturbation.
In terms of single strand break repair, there are a number
of nucleotide-excision repair (NER) (n=16) genes differentially expressed in the distal colon in response to AOM
treatment and 80% of them were up-regulated. This is
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Figure 3 Box plots demonstrating gene expression (microarray dataset) six hours after AOM treatment in the proximal and distal
colonic epithelium for the genes: H2AFX (H2A histone family member X), MGMT (O-6-methylguanine DNA methyltransferase), Xrcc4
(X-ray repair complementing defective repair in Chinese hamster cells 4), MSH3 (mutS homolog 3 (E. coli)), Apex1 (apurinic/apyrimidinic
endonuclease 1), Pol β (polymerase, DNA directed beta), MBD1 (methyl-CpG binding domain protein 1), MDM2 (p53 E3 ubiquitin protein
ligase homolog), OGG1 (8-oxoguanine DNA glycosylase).

important as NER is the most flexible of the DNA repair
pathways as it repairs bulky DNA lesions [21]. Other
base-excision repair associated genes also showing increased
expression in response to treatment with AOM include
Apex1 (apurinic/apyrimidinic endonuclease 1) had a 1.6 fold
change and Polβ, (polymerase, DNA directed beta) a 1.4
fold change (see Figures 3). The mismatch repair (MMR)
pathway is an important pathway involved in the DNA
damage response to carcinogen induced lesions resulting
in cell cycle arrest and, at high lesion load, apoptosis
[22]. However, AOM treatment led to the down-regulated
response of MMR genes (n=4). For instance, MSH3 (mutS
homolog 3 (E. coli)), which recognises insertion/deletion

mismatches containing two or more extra bases [23]
showed decreased expression (−2.1 fold change) with
AOM (Figure 3). These observations suggest that the
MMR pathway in general may be down-regulated in
response to AOM and are consistent with AOM’s major
mode of action involving DNA adduct formation and
induction of point mutations rather than the formation of
multi-base mismatches.
Double-strand breaks (DSB), in which both strands in the
DNA double helix are severed, are particularly hazardous
to the cell because they can lead to genome rearrangements
[24]. DSB repair via homologous recombination (HR) is an
important process as it takes place late in the S- and G2-
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treatment other cellular processes such as cell cycle arrest
and apoptosis becomes more important in maintaining
mucosal integrity in response to this genomic insult.
To investigate the biological consequences of unrepaired
DNA damage, such as the O6-mdGua lesions, the
functionality of the top 800 genes differentially expressed
in response to AOM in the proximal and distal colon, was
examined through pathways analysis. The top 12 pathways
in which the highest percentage of component genes
displayed AOM-associated differential expression relative
to the saline treated control in the distal and proximal
colonic mucosa are shown in Figure 4. There was a
number of cell cycle regulation pathways differentially
expressed in the distal colon 6 hours after the treatment
with AOM. These included, “p53 signalling” and “Cell cycle
regulation by B cell translocation (BTG)” (see Figure 4
for more cell cycle pathways). This is noteworthy as

phases of the cell cycle to prevent unrepaired double strand
breaks from causing down-stream problems in transcription, replication and chromosome segregation [25]. In the
distal colon there were nine genes from this pathway
up-regulated in response to AOM. For instance, Xrcc2,
which plays a central role in this pathway and encodes a
member of the Rad51 family of proteins, was up-regulated
1.5-fold. Conversely, the DSB repair via non-homologous
end-joining (NHEJ) pathway was down-regulated with
AOM, demonstrated by the decreased expression of Xrcc4
(X-ray repair complementing defective repair in Chinese
hamster cells 4, -1.94 fold change) (Figure 3). Consequently,
there is some evidence that single and double strand break
repair functions may be compromised in response to AOM
treatment. These data coupled with the accumulation of
unrepaired O6-mdGua lesions in colonic epithelium in
response to carcinogen, indicates that at six hours post
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Figure 4 The top 12 pathways differentially expressed in response to AOM in the distal and proximal sections. Depicted as up □), down
(■) or no overlap with the dataset (i.e. genes in the canonical pathway but not differentially expressed) (gray square symbol).

Kerr et al. BMC Physiology 2013, 13:2
http://www.biomedcentral.com/1472-6793/13/2

deregulated cell cycle processes are a prominent feature
of oncogenesis [25]. Overall, the response suggests a
trend towards cell cycle arrest in response to AOM.
DNA damage checkpoint control mechanisms tightly
regulate progression through the cell cycle, ensuring the
fidelity of cell division which is an important self-defence
mechanism for the maintenance of genome stability [26].
A number of observations support the involvement of the
p53 signalling (see Figure 5) and BTG pathways in AOMinduced cell cycle arrest in the distal colon: Cyclin G1, a
protein involved in G2/M phase arrest and regulates p53
[27] expression increased 4.34 fold; cyclin dependent
kinase inhibitor 1 (p21Cip1), which inhibits the activity of
cyclin-CDK2 or -CDK4 complexes [28], is marginally upregulated, and as a result Retinoblastoma 1 (Rb1) is downregulated (1.5 fold); BTG family member 2 (BTG2), an
important transcriptional regulator that impairs G1-S cell
cycle progression [29] increased 2.34 fold and MDM2
(p53 binding protein homolog, 2.81 fold change increase)
(Figure 3) which is also a member of another expressed
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pathway, “Cell Cycle: G2/M DNA Damage Checkpoint
Regulation” (p= 0.002). This latter cell cycle pathway has
other genes differentially expressed. For example, Chek1,
which is a checkpoint regulator of cell cycle arrest and
putative tumour suppressor in response to DNA damage
[30], is up-regulated (1.6 fold change). Most cancer cells
harbour mutations in tumour suppressors and/or oncogenes which would normally control cell cycle checkpoints
[26]. Therefore, cell cycle regulation is important in the
maintenance of genomic stability and to prevent cells that
have undergone malignant transformation progressing
through the cell cycle phases.
The p53 signaling pathway (pvalue 1.66×10-4) is
significantly expressed (the second most highly expressed
pathway in the distal colon) in response to AOM. Loss of
p53 function is thought to be a contributing factor in
colorectal cancer, because the p53-dependent pathway
shuts down damaged cells, either through apoptosis,
cell-cycle arrest or cellular senescence [31]. Apoptosis
was observed histologically to have significantly increased

Figure 5 p53 signalling pathway in the distal colon in response to AOM “red circle symbol” up-regulated and “green circle symbol”
down-regulated). Details of the expressed genes can be found in Additional file 1: TableS4.
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Figure 6 Apoptotic indices (% apoptotic cells per crypt height) of the proximal and distal colonic epithelium of rats 6 h after injection
with saline (−AOM) and AOM (+AOM) as determined by morphological assessment of the colonic mucosa. Data are mean±SEM (n=20).
Means within the same colonic section with different superscripts are significantly different (P<0.0001).

at six hours after the AOM treatment (Figure 6). As
MGMT is depleted at this time point, we hypothesise that
the main cellular response to AOM involves the early
depletion of MGMT then a switch to the induction of
apoptosis and this most likely first occurs through the p53
signalling pathway. This is demonstrated through closer
examination of the p53 signalling pathway response to
AOM in the distal colon (see Figure 5). Firstly, genes such
as TP53INP1 (tumour protein p53 inducible nuclear
protein 1), which is a key transcriptional regulator that
responds to a variety of cellular stresses, including DNA
damage, oxidative stress and activated oncogenes, to
regulate key cellular processes including the induction of
apoptosis [32], is up-regulated 1.5 fold. Furthermore,
Caspases 1 (Casp1) and Casp3 are up-regulated in response
to AOM in the distal colon (1.2 fold change for both). The
activation of Casp3 triggers an execution arm of the
apoptosis response initiating DNA fragmentation [33]. The
apoptotic function of caspases is regulated by the Bcl-2
family of proteins [34]. Accordingly, in response to AOM,
Bcl-associated X protein (Bax) which is critically important
in the up-regulation of apoptosis, is increased two fold.
Furthermore, there is also decreased expression of the
caspase-activated inhibitor Avon by 1.2-fold. Therefore,
these results indicate that at 6 hours after being treated
with AOM, one of the major effects of this carcinogen
occurs through the p53 signalling pathway and the result is
cell cycle arrest and a cellular switch towards apoptosis.
Gene network analysis was used to further understand
the function of genes expressed in response to AOM in
each colonic segment, in particular the early induction
of apoptosis. When the top three AOM/proximal

networks were merged (Figure 7) there were 13 genes with
functional annotations (p= 7.16×10-4) associated with
colorectal cancer including the up-regulation (1.6-fold) of
transcriptional regulator c-JUN (jun proto-oncogene) and
the down-regulation of MGMT (1.4-fold). In terms of the
AOM/distal network there were eight genes associated with
colon cancer (p= 5.04×10-4), including the transcriptional
regulator MYC (up-regulated 1.6 -fold) and the previously
mentioned c-JUN (Figure 8). When the p53 signalling
pathway and apoptosis genes were cross-referenced in this
network, c-Jun Kinase (JNK), which regulates cJUN and is
an important regulator of cell death [35], was a gene
common to both and is linked through the gene network
to the down-regulated p53 signalling transcriptional
regulator, Retinoblastoma 1 (Rb1). Taken together these
results suggest that the early genomic damage effects of
AOM on the colonic mucosa may be mediated through
the p53 pathway, favouring apoptosis through c-JUN/
JNK signalling and preventing cell cycle progression
through reduced Rb1 expression. Whilst this mechanism
is hypothetical, it provides a framework for the further
elucidation of the key mechanisms underpinning the
cellular switch towards apoptosis in the gut mucosa in
response to alkylating carcinogen challenge.

Conclusion
The healthy rat colonic mucosa exhibits extensive gene
expression changes from its proximal to distal end
reflecting regional changes in metabolic function. The
normal rat colon also has naturally occurring protective
and genomic repair mechanisms expressed dynamically,
albeit subtly, along the proximal/distal axis. Six hours

Kerr et al. BMC Physiology 2013, 13:2
http://www.biomedcentral.com/1472-6793/13/2

Page 9 of 13

Figure 7 Network expression in the proximal rat colon 6 hours after the administration of AOM. The top 800 differentially expressed genes were
networked and the top three networks were merged. Genes relevant to two cancer pathways and individual cancer related genes are highlighted.

after administration of AOM, substantial changes in
gene expression have occurred in the colonic mucosa
and these also differ along the length of the colon. The
changes are greater in the distal colon and appear
particularly associated with the sensing of genomic damage,
associated cell cycle arrest and a cellular switch towards
the induction of apoptosis. Consequently, the genomic
homeostasis mechanisms that naturally exist to combat
dietary and environmental insults in the colon of the
normal rat appear to be dysregulated by AOM resulting in
a cellular switch through p53 signaling to more efficient
genes associated with the apoptotic response, a genetic
response that is also reflected histologically.

Methods
Animals and diets

Forty male Sprague Dawley rats weighing approximately
176 ± 2.4 g were purchased from the Animal Resource
Centre, Western Australia. They were housed in wirebottomed caging in a temperature controlled room

(22-24°C) with a 12 h light/dark cycle. They were randomly
allocated into two groups (n=20) with approximately equal
body weights. They were given free access to water and a
modified AIN-93G diet [36]. Both groups were fed this diet
for 28 days. One group was then injected subcutaneously
with azoxymethane (AOM; 15 mg/kg; Sigma Chemical Co.,
St. Louis, MO, USA) the other with saline. Six hours after
injection the rats were anaesthetised with isoflurane and
killed by exsanguination. The large bowel (excluding the
rectum) was removed, opened longitudinally along the
mesenteric border and digesta removed. The colon was
rinsed clean with PBS and transferred to a chilled ceramic
plate for dissection. The colons were on average 15 ± 0.5
cm long. The last 0.5 cm distal and first 0.5 cm proximal
sections of the colon were discarded and the next 2 cm
from both ends placed into 10% buffered formalin (Sigma)
for morphological assessment of apoptosis. Mucosal
samples for gene expression and protein analyses were
collected by scraping the next 4 cm of proximal and
distal colon with new microscope slides. The mucosal

Kerr et al. BMC Physiology 2013, 13:2
http://www.biomedcentral.com/1472-6793/13/2

Page 10 of 13

Colours
Up with AOM
Down with AOM

Figure 8 Network expression in the distal rat colon 6 hours after the administration of AOM. The top 800 differentially expressed genes
were networked (IngenuityW) and the top three networks were merged. Genes relevant to two cancer pathways and individual cancer related
genes are highlighted.

samples were placed in RNAlater (Sigma Chemical Co.,
St. Louis, MO, USA) and then stored at −80°C for later
processing. All instruments were replaced or cleaned
thoroughly between animals.
All procedures involving animals were approved by
the Commonwealth Scientific and Industrial Research
Organisation (CSIRO) Human Nutrition Animal Ethics
Committee and complied with the Australian code of
practice (2004). [http://www.nhmrc.gov.au/publications/
synopses/ea16syn.htm].

validated technique [37]. The number of apoptotic cells
was identified by cell shrinkage, presence of condensed
chromatin, and sharply delineated cell borders surrounded
by a clear halo as described by [38]. All histological analyses
were performed in a blinded fashion by a single operator.
The rates of apoptosis for each section of colon (±AOM)
were analysed with Mann Whitney t-tests using GraphPad
Prism Version 4.00 (GraphPad Software Inc. San Diego,
CA, USA). Data are expressed as mean ± standard error of
the mean (SEM).

Measurement of crypt height and colonocyte apoptosis

Acquisition and data analysis

The rate of apoptosis was determined on paraffinembedded sections (4 μm) stained with haematoxylin
(Harris’, BDH Laboratory Supplies, England). An Olympus
BX-41 light microscope (Olympus Corp., Japan) was
used to identify 20 randomly chosen intact crypts and to
determine the crypt height by counting the total number of
cells from the base to the lumen using a previously

Proximal and distal sections from ten rats were used
from each group. It was ascertained in a preliminary
study that investigated baseline variation in this model
and tissue type, that n=10 was a sufficient sample
(see Gene Expression Omnibus (GEO) accession number
GSE13802 for the complete dataset of this pilot study).
The distal and proximal colonic mucosal samples from
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the AOM and saline treated rats were removed from the
RNAlater stabilisation reagent (Sigma, Australia) and placed
in 1ml of TRIzolW Reagent (Invitrogen, Sydney, N.S.W.,
Australia). Samples were then homogenised using
beads (mix of 2.5 mm glass and 0.1 - 1.0 mm diameter
silicon-zirconian beads) in a MiniBeadbeater-8™ (BioSpec
Products Inc. Oklahoma, US). Total RNA was extracted
according to the TRIzolW Reagent manufacturer’s instruction after which samples were further purified using
RNAeasy mini spin columns (QIAGEN, Doncaster,
Victoria, Australia) with a DNase on-column digestion
as per the manufacturer’s instructions. The integrity of the
RNA was checked using a Bioanalyzer 2100 (Agilent
Technologies) and quantified using a NanoDropW
ND-1000 Spectrophotometer. Ten AOM rat and nine
saline rat proximal and distal colonic epithelia (one saline
set was dropped due to substandard RNA quality), i.e. 38
RNA (4.5 μg) samples, were processed for microarray
expression analysis using high-density oligonucleotide
arrays (AffymetrixW GeneChip array, AffymetrixW, Santa
Clara, CA, USA) commensurate with the manufacturer’s
instructions. The complete microarray dataset from this
study can be sourced at NCBI’s Gene Expression Omnibus
(GEO accession GSE15184).
AffymetrixW Gene Chip Rat Expression 230W results
were analysed using the PartekW genomics suite software
for differential expression, using an RMA normalization
method. This software was used to Principal Component
Analysis (PCA) which is a mathematical algorithm that
reduces the dimensionality of the data by identifying directions, called principal components (e.g. PC1, PC2, etc.),
along which the variation in the data is maximal [39].
The results were then plotted so that it is possible to visually assess similarities and differences between samples
and determine whether samples can be grouped. The Partek software was also used to generate lists of differentially expressed genes by obtaining estimates of variance
components for mixed models, using the method of
moments estimation [40], restricted maximum likelihood
estimation (REML) [41], and minimum variance quadratic unbiased estimation (MIVQUE) [42] using Analysis of Variance model that included rat number,
colonic position (proximal or distal) and treatment
(AOM or saline). As there is multiplicity of genes in
microarray datasets, particularly for genes with small
standard errors that can generate false discoveries, we
used the False Discovery Rate (FDR) [43] to restrict our
gene lists beyond p-values. The Gene Ontology Biological
Processing and Molecular function terms [44] were added
to the lists of differentially expressed. Individual gene data
is presented using Box and Whisker plots which describes
the dataset on an interval scale, i.e. as explanatory data analysis, to demonstrate the shape of the distribution, its central value, and its variability. The ends of the box are the
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upper and lower quartiles, so the box spans the interquartile range, the median is marked by a vertical line inside the box and the whiskers are the two lines outside the
box that extend to the highest and lowest observations.
Pathway and network expression

While the characterization of each gene that is differentially
expressed in response to AOM as outlined above provides
useful data, the identification of specific pathways that are
changed in response to the AOM treatment is important
for understanding the early changes that occur at a
transcriptome level. To further understand the biology of
gene expression comparisons, beyond the lists of expressed
gene, pathway and network analysis was also performed
using Ingenuity Pathway Analysis (IngenuityW Systems,
Inc., Redwood City, CA, USA, http://www.ingenuity.com),
a curated knowledge base with over 1·5 million entries to
determine the pathways that are perturbed by AOM. IPA
identifies differentially expressed pathways based on the
probability of having the observed number of differentially
expressed genes associated with the dataset for that pathway in Ingenuity’s propriety database, by random chance
and the p-value is calculated with the right-tailed Fisher’s
Exact Test (IngenuityW Systems, www.ingenuity.com). This
analysis was applied to lists of the top 800 differentially
expressed genes from comparisons of normal proximal rat
colon to normal distal rat colon and the AOM-induced
changes in both the proximal and distal colon. The gene
network analysis was performed as described by [45] and
IngenuityW Systems, www.ingenuity.com.
Real-time PCR validation

As there is a risk of false discovery associated with
microarray experiments (see above) it is important to
verify data using an independent technology platform
such as RTPCR. As a result the top eight differentially
expressed genes between proximal and distal rat colon
that were identified by microarray data analysis were
chosen to be a representative subset and were measured
by qRTPCR using TaqManW Universal PCR Master Mix
commensurate with the manufacturer’s instructions).
Reactions were performed in 20 ul reaction volumes
using an ABI PRISMW 7700 Sequence Detection System.
Data were normalised using the Relative Quantitation of
Gene Expression method as outlined in the ABI 7700
manual. An aliquot of any given RNA sample used for
microarray gene expression analysis was reverse-transcribed
to provide the substrate for qRTPCR quantification.

Additional file
Additional file 1: Table S1. The complete listing of transcript contrasts
between proximal and distal in the normal epithelium (saline); between
saline and AOM epithelium in the proximal and between saline and AOM
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epithelium in the distal colon. Table S2. A) Genes with Gene Ontology
Biological Processing term associated with DNA damage and repair in the
AOM versus saline contrast in the proximal colon. B) Genes with Gene
Ontology Biological Processing term associated with DNA damage and repair
in the AOM versus saline contrast in the distal colon. Table S3. Summary of
genes validated by real time PCR for microarray differential expression. Genes:
UDP-GlcNAc: betaGal beta-1,3-N-acetylglucosaminyltransferase 7, solute
carrier family 34 (sodium phosphate), member 2; similar to Nacetylglucosamine 6-O-sulfotransferase (predicted), peroxiredoxin 6, homeo
box D10 (predicted), protein kinase, cAMP dependent, catalytic, beta;
cytochrome P450, family 4, subfamily f, polypeptide 1 and cancer
susceptibility candidate 4 (predicted). Table S4: Details of the genes
expressed in the p53 signaling pathway.
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